10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 250 filers reported holding 10X GENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,196,156 | +18.9% | 101,725 | +61.0% | 0.10% | +14.1% |
| Q2 2023 | $3,528,362 | +44.8% | 63,187 | +44.6% | 0.09% | +37.3% |
| Q1 2023 | $2,437,242 | -63.8% | 43,686 | -76.3% | 0.07% | -64.9% |
| Q4 2022 | $6,726,241 | +229.2% | 184,584 | +157.3% | 0.19% | +165.3% |
| Q3 2022 | $2,043,000 | +440.5% | 71,750 | +758.3% | 0.07% | +323.5% |
| Q2 2022 | $378,000 | -73.9% | 8,360 | -56.2% | 0.02% | -75.0% |
| Q1 2022 | $1,451,000 | -48.6% | 19,077 | +0.7% | 0.07% | -60.9% |
| Q4 2021 | $2,822,000 | +583.3% | 18,942 | +799.0% | 0.17% | +397.1% |
| Q2 2021 | $413,000 | -87.2% | 2,107 | -90.7% | 0.04% | -89.7% |
| Q4 2020 | $3,218,000 | +148.9% | 22,729 | +119.2% | 0.34% | +310.8% |
| Q3 2020 | $1,293,000 | +167.7% | 10,370 | +91.9% | 0.08% | +144.1% |
| Q2 2020 | $483,000 | – | 5,405 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |